Veraxa Biotech AG (VRXA)

• Market cap: $249M
• 1 day: -10.2%
• 5 days: -6.88%
• 1 month: -6.38%
• 3 months: -92.9%
• 6 months: -92.9%
• Year to date: -92.9%
• 1 year: -92.9%
• 5 years: -92.9%
• 10 years: -92.9%
• Sector: Healthcare
• Industry: Biotechnology

About: Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.